This conference book is your guide to our annual Local Champions Mid Cap Conference set to take place on Thursday, 11 December 2025 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or attend small group sessions with the top management and/or IR of the following companies: BARCO | BEKAERT | DECEUNINCK | DEME | EVS | IBA | JENSEN GROUP | MATERIALISE | ONTEX | PROXIMUS | RECTICEL | XFAB
A director at Materialise Nv sold 590,000 shares at 6.020USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Materialise NV Announces Results of 2025 Extraordinary Shareholders’ Meeting Leuven, Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing solutions, today announced the results of the votes cast at its Extraordinary Shareholders’ Meeting, where all the proposed resolutions were approved. For additional information, please visit: About Materialise NV Materialise NV incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing...
We keep our HOLD rating but lower our target price from €9.50 to €8.50 reflecting our lowered estimates. 3Q25 beat ING estimates but the revenue trend in NL disappointed and showed the early impact from the upcoming pension regulatory changes, which also leads us to lower our estimates for FY26-27F. Brunel has taken additional cost-cutting measures to offset these pressures and to protect margins in NL and Germany. Brunel Germany seems to have stabilised and further supplier rationalisation shou...
Adyen: Preview Investor Day Aperam: In line 3Q25 EBITDA, soft 4Q25 guidance balanced by optimism on EU trade action and FCF beat Brunel: 3Q25 beats; outlook FY25 in line but trend NL and cash position weaker CM.com: Rejects Bird's offer Euronext: Records, beats, buybacks and upgrades GBL: 3Q25 a bit light Kinepolis: Canadian peer Cineplex 3Q25 Results and October 2025 Box office revenue NEPI Rockcastle: COO appointed as new CEO Proximus: Major cut to Global 2026 EBITDA, in line 3Q, 2025 FCF guid...
Brunel Q3 2025 results: Driving operational efficiency Amsterdam, 7 November 2025 – Brunel International N.V. (Brunel; BRNL), a global specialist delivering customised project and workforce solutions to drive sustainable industry transformations through technology and talent, today announced its third quarter and first nine months results. Q3 2025 Key points Revenue of EUR 304.0 million, down 10% (down 7% organically)Gross profit of EUR 56.5 million, down 16% (down 14% organically)Underlying EBIT of EUR 11.9 million, down 31% (down 29% organically)Cost reduction programs delivered EUR 5.1...
Materialise to Hold Extraordinary Shareholders’ Meeting on November 14, 2025 LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host an Extraordinary Shareholders’ Meeting on Friday, November 14, 2025, at 17:00 CET. The Extraordinary Shareholders’ Meeting will take place on November 14, 2025 at 17:00 CET at the registered office of the Company (Technologielaan 15, 3001 Leuven). The deed will be digitally executed by notary Stijn Raes...
In addition to the positive net result and strong cash flow in 3Q25, we were pleased to note that Materialise's Medical Segment achieved a record quarterly revenue, growing over 10% y/y. This performance stands out against a backdrop of ongoing macroeconomic headwinds, which continued to weigh on its overall revenues—particularly within Manufacturing. Materialise highlighted it further implemented targeted cost control measures designed to protect its operational profitability without compromisi...
Adyen: 3Q25 results – solid net revenue, FY25 guidance reiterated. Aedifica: Guidance raised, positive tenant trends and good portfolio valuation. Ageas: China Taiping Life 3Q25 Solvency much lower, remains solid. Allfunds Group PLC: Strong flows. ASM International: 3Q25 results - disappointing orders, much better margins. Corbion: Iron wills and nerves of steel. Lotus Bakeries: peer Mondelez 3Q25 results. Melexis: 3Q25 results, ongoing gross margin pressure. Staffing: Dutch figs...
We downgrade Brunel from Buy to HOLD as the valuation argument is not strong enough to outweigh the short-term earnings risk we still see in key markets. We have lowered our estimates significantly post 2Q25 results reflecting the lack of a recovery while we see regulatory risks in NL, no signs of a German bazooka to provide support while Global Businesses faces some headwinds in certain regions due to project delays, slower momentum in Americas and Australasia while in general being impacted by...
Alfen: Preview - muddling through? Belgian telcos: Competition Authority investigation on Proximus/Orange Belgium MoU. Brunel International: 2Q25 below, 3Q25 outlook cut, cost savings protect FY25 estimates. Euronext: Another record set of results. Fugro: Sharper V-shape? GBL: Weak NAV performance, as expected. KBC Ancora: Cooperative CERA increasing its stake to 51.24%, using excess cash. UCB: Renewed US threats to cut drug prices. Umicore: 1H25 and guide broadly in-line, new S...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.